Q&A: USC researchers uncover potential osteoarthritis treatment breakthrough with R805/CX-011

The left image depicts osteoarthritic cartilage damage in animal studies without any treatment, while the right image reveals articular cartilage regeneration following a knee injection of the novel drug R805/CX-011. [Image: Evseenko Lab/USC Stem Cell]

Researchers at the Keck School of Medicine at the University of Southern California (USC) have discovered a drug compound, R805/CX-011, with the potential to alleviate the painful hyperinflammation from osteoarthritis. The findings concerning the prospective osteoarthritis treatment breakthrough, published in Science Translational Medicine, showed positive effects in animal models and could pave the way for human trials.

We recently had the opportunity to speak with Dr. Denis Evseenko, a professor of orthopedic surgery, stem cell research, and regenerative medicine at the Keck School of Medicine, about the research. In the Q&A, Dr. Evseenko discusses the poten…

Read more
  • 0